Cite
HARVARD Citation
Kim, S. et al. (2019). Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists. Expert review of clinical immunology. pp. 211-213. [Online].